Banco Santander S.A. Makes New Investment in Corteva, Inc. $CTVA

Banco Santander S.A. acquired a new stake in Corteva, Inc. (NYSE:CTVA) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 179,664 shares of the company’s stock, valued at approximately $12,151,000.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Corteva by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock valued at $5,976,436,000 after acquiring an additional 373,680 shares during the last quarter. Geode Capital Management LLC increased its stake in Corteva by 1.4% in the second quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock valued at $1,339,651,000 after purchasing an additional 251,693 shares during the last quarter. Franklin Resources Inc. lifted its position in Corteva by 4.9% during the second quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock worth $1,317,708,000 after buying an additional 824,451 shares during the period. Norges Bank acquired a new stake in Corteva in the 2nd quarter worth about $434,220,000. Finally, Bank of New York Mellon Corp grew its holdings in Corteva by 2.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,256,845 shares of the company’s stock valued at $391,793,000 after buying an additional 138,484 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.14% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CTVA. Mizuho increased their price objective on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Royal Bank Of Canada upped their price objective on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and an average price target of $82.30.

Corteva Price Performance

Shares of NYSE CTVA opened at $80.01 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.23. The company has a market capitalization of $53.81 billion, a price-to-earnings ratio of 50.64, a PEG ratio of 2.69 and a beta of 0.75. The business has a 50-day moving average of $71.91 and a 200-day moving average of $68.83.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.